Sort   by:  
 Page size 
UnknownDiscovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease.
Not available
S-EPMC8525223 | biostudies-literature
UnknownRandomized Sham-controlled Trial of Targeted Lung Denervation in Patients with Chronic Obstructive Pulmonary Disease (AIRFLOW-3).
Not available
S-EPMC12700255 | biostudies-literature
UnknownMaraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.
Not available
S-EPMC4614410 | biostudies-literature
UnknownTransformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Not available
S-EPMC12481261 | biostudies-literature
UnknownDeterminants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Not available
S-EPMC11795382 | biostudies-literature
Sort   by:  
 Page size